Skip to main content
. 2022 Feb 1;22:208. doi: 10.1186/s12889-022-12531-3

Fig. 4.

Fig. 4

Actual and alternative prevalence trend. The 2025-target prevalence is 75% of the prevalence in 2011. Compound biannual growth rate was used to construct the 25% relative reduction target trajectory from 2011 to 2025